Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer: early-phase trial registry
279 of 621 indexed Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #6 of 28,963 conditions by registered trial count.
621 US clinical trials · 279 currently recruiting · #6 of 28,963 conditions by registered trial count
Cancer: 621 US clinical trials tracked, 279 recruiting.
Cancer is the subject of 621 registered US clinical trials on ClinicalTrials.gov, 279 of them currently open to new participants. 31 are in Phase 3-4 (later-stage) and 164 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 31 of these trials.
Open enrollment, early-phase tilt
Cancer has 621 registered US clinical trials, 279 of them open to new participants right now, about 45% of the total.
- 279
- recruiting participants now
- 45%
- of trials open to enrollment
- 31
- in Phase 3-4 (later-stage)
- 31
- top sponsor: M.D. Anderson Cancer Center
Corpus placement: #6 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Cancer on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer is recruiting above its size-band peers.
279 of 621 indexed trials (44.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 31 of 621 trials (5%). 270 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer enrolment sits around 108 participants.
Median target enrolment is 108 among the 616 trials that report a genuine target (sentinel values excluded). 287 of those (46.6%) plan for fewer than 100 participants.
-
Cancer research is mostly interventional.
462 interventional and 159 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
621 total, page 5 of 13
Support for Bereaved Cancer Caregivers
Michigan State University
NCT06662409
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
Case Comprehensive Cancer Center
NCT06446115
Massage Impact on Sleep in Pediatric Oncology
Children's Hospital of Philadelphia
NCT06892158
A Study of Herbal Supplements in Cancer Survivors With Constipation
Memorial Sloan Kettering Cancer Center
NCT07091084
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Northwell Health
NCT03213002
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
University of Southern California
NCT04333706
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
Memorial Sloan Kettering Cancer Center
NCT07454330
Intervening on Women's Health for Rural Young Cancer Survivors
University of California, San Diego
NCT06664034
Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors
University of Pittsburgh
NCT06475807
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Memorial Sloan Kettering Cancer Center
NCT06915116
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
Jona Hattangadi-Gluth
NCT04343157
Rehabilitation Outcomes Study
UNC Lineberger Comprehensive Cancer Center
NCT06674889
Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers
University of Rochester
NCT06505122
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
M.D. Anderson Cancer Center
NCT05681026
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
M.D. Anderson Cancer Center
NCT05053867
Text -Based Depression Screening Among Cancer Survivors
Medical University of South Carolina
NCT06894849
Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors
Medical University of South Carolina
NCT07091968
Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer
Case Comprehensive Cancer Center
NCT07167056
A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients
M.D. Anderson Cancer Center
NCT06127121
Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer
Sunstone Medical
NCT05947383
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
Alain Algazi
NCT03708224
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
University of Alabama at Birmingham
NCT07197515
Group Advanced Care Planning Pilot for Veterans
VA Palo Alto Health Care System
NCT06646614
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
UNC Lineberger Comprehensive Cancer Center
NCT05145400
Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)
HealthPartners Institute
NCT07107607
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Vanderbilt-Ingram Cancer Center
NCT06915454
Impact of the Coronavirus (COVID-19) on Patients With Cancer
Stanford University
NCT04330521
Yoga to Improve Disparities in Cancer Survivorship
University of California, San Francisco
NCT07165600
Patient Derived Preclinical Models
Mayo Clinic
NCT05324553
ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area
H. Lee Moffitt Cancer Center and Research Institute
NCT07218848
Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application
University of Pittsburgh
NCT07218874
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors
TOLREMO therapeutics
NCT06403436
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NCT06731998
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Baptist Health South Florida
NCT05789589
Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers
Yale University
NCT07224204
Optimizing Care for Cancer Survivors With Depression: Project 3
Medical University of South Carolina
NCT06930729
Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
Duke University
NCT06732375
Care Coordination Educational Intervention Study for Patients from Rural Areas with Early Stage Cancer
University of Vermont Medical Center
NCT05723250
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Stanford University
NCT05415007
Adaptation of a Values Assessment Tool
UNC Lineberger Comprehensive Cancer Center
NCT07068477
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
Medstar Health Research Institute
NCT07318519
A Novel Intervention for Patients With Cancer
Dana-Farber Cancer Institute
NCT05643027
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
M.D. Anderson Cancer Center
NCT06667427
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
Dana-Farber Cancer Institute
NCT03310879
COBRA: Cancer, Older Adults, Balance and Resistance Activities
Memorial Sloan Kettering Cancer Center
NCT07011862
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
University of Cincinnati
NCT06416007
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
University of California, Irvine
NCT07073807
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
University of Hawaii
NCT06237816
A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy
Sutter Health
NCT06706752
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Medical University of South Carolina
NCT06451003
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 116 |
| Phase 2 | 48 |
| Phase 3 | 27 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Cancer right now
279 recruiting of 621 indexed (45% open).
Phase mix: 31 late (III/IV) vs 164 early (I/II) (early-phase heavy).
Top sponsor: M.D. Anderson Cancer Center (31 trials), 9 others listed. 50 shown below, recruiting first. #6 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Cancer?
PlainTrial tracks 621 US clinical trials for Cancer, of which 279 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Cancer?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.